Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-038035

Director acquired 3,253 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cole Douglas G. Director 2021-06-01 Option exercise +3,253 3,253 D
Derivatives
Cole Douglas G. Director 2021-06-01 Option exercise · Restricted Stock Units −3,253 0 D
Loading xslF345X03/doc4.xml…